about
The Warburg effect and drug resistanceExtracellular nicotinamide phosphoribosyltransferase, a new cancer metabokinePresent and future pharmacotherapeutic agents in heart failure: an evolving paradigmCentral nervous system toxicity of mefenamic acid overdose compared with other NSAIDs: an analysis of cases reported to the United Kingdom National Poisons Information ServiceExercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonistsPharmacogenomics of off-target adverse drug reactions.Drug repurposing from the perspective of pharmaceutical companies.The oxidative stress theory of disease: levels of evidence and epistemological aspects.The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.Nutraceuticals in hypercholesterolaemia: an overview.The potential health effects of dietary phytoestrogensLack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult womenInfluence of inflammation and nitric oxide upon platelet aggregation following deposition of diesel exhaust particles in the airways.Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injuryOzanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.Redox-based therapeutics in neurodegenerative disease.Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system.Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients.Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment.Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib.Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function.TRPA1 activation leads to neurogenic vasodilatation: involvement of reactive oxygen nitrogen species in addition to CGRP and NOSystematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.Mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone induces vasorelaxation without involving KATP channel activation in smooth muscle cells of arteriesPatterns of antiplatelet drug use after a first myocardial infarction during a 10-year period.Development of an in vivo target-engagement biomarker for TRPA1 antagonists in humans.Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers.Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study.Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in miceMonoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.Involvement of Rac1 signalling pathway in the development and maintenance of acute inflammatory pain induced by bee venom injectionDistinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucosePossible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth.Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries.Digoxin reduces atherosclerosis in apolipoprotein E-deficient micePnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidaseD-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase.
P2860
Q26770007-0293F792-B784-49B0-93CC-C04805A5D6B2Q28069876-BDC802E4-CA7A-4E6A-BE95-85EB5631195DQ28077186-72685FC4-6EB9-4C7D-85B3-852AD0060F19Q29248481-06AA8AC0-81C4-49EB-9BE8-C357D655BC8EQ30238666-5514AC90-A550-4834-A580-747E42A28511Q30359656-05FAA6E6-7D02-48D3-8716-102D3C192170Q30400366-C3D13F36-E33C-4922-ABD2-F21516961684Q30400634-2F535888-91DA-472D-8E53-2AC16FFB358CQ30489579-F0F3158A-1C2F-4E41-915D-CD04D6EE9D90Q31122398-F06E68A8-BC3B-45FB-B550-C18A4DDF6413Q33434017-CB8A08B5-4B84-48F7-980D-CBDD996C39B4Q33676445-77C6D008-2378-4FCB-83FD-0ED97276B07AQ33676455-C859B5FF-A08F-45D4-8FD3-563CCE762F4AQ33780895-EC34B47F-F0C3-48ED-9DDE-68E403ADE864Q33784212-D853C0BA-99C6-4ED2-98F5-FD19F087BD36Q33826729-1A0FCC0A-59F3-427D-9107-4DDAFF02B8ADQ34518822-4FCE630B-C1C8-4885-ADBF-814F64179F74Q34535918-48C02BCC-5F17-43FB-A3CE-7C61A809B7EFQ34549418-114E7477-27E7-4600-AAA7-B0493BB6A445Q34555590-EA1F1379-95A8-4EC8-96CD-062025D776DDQ34556039-3797DC6B-5AAA-42DC-B52B-74B1086C88C2Q34556733-B52B7149-A5ED-4FE3-9911-D6A4D007B7AEQ34680436-6480B042-A6FA-46CE-8260-371A72B9307FQ35851832-5400C75A-148B-4E67-BBED-7650744BCD92Q36020464-35C17391-CEE2-48D5-B3A6-FDFF0B909841Q36091331-1C0C8035-9139-4ED5-946E-35E72DE56AD6Q36106217-AEEAA4AA-62B7-43BA-B162-4E8FCD309363Q36143090-E946FEA7-B737-4645-B983-37D70617AE65Q36148650-08D5090D-69C1-48B2-AD41-85CBB36152B8Q36264439-E9D02362-F49B-4749-89D4-839E58B06F0AQ36310002-7887F5E7-7A05-4760-A50D-FD2E88A53153Q36599618-E7E07C25-8537-4F5D-9EB1-007D4A4B4FE1Q36599623-ED4C5B55-6A28-46DE-B087-87E1D1999008Q36599633-0560C5E0-C70D-4DEA-A09B-01161B73F3F5Q36599646-26696B8E-DCC6-4F83-A18B-A51880C5F48CQ36599652-347C9CC0-CC89-46A3-9FCD-B41BEF65EF0FQ36599656-7E726E86-277F-4C26-8A9C-8F6328FDA0CCQ36797363-73A7600A-5A82-4B39-B08A-58D9D4992DEDQ36797368-2A725ED1-902A-42FB-ABF7-9137B5AEDA5AQ36797373-DAA2129E-3C97-45A6-961F-C39C676B042B
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@ast
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@en
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@nl
type
label
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@ast
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@en
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@nl
prefLabel
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@ast
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@en
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@nl
P2093
P50
P3181
P356
P1476
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
@en
P2093
CGTP Collaborators
Doriano Fabbro
Eamonn Kelly
Helen E Benson
John A Peters
Neil Marrion
P304
P3181
P356
10.1111/BPH.13354
P407
P577
2015-12-01T00:00:00Z